Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat
about
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expressionHistory and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccinesSeasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenariosInfluenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern AsiaThe Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A.Influenza activity in Thailand and occurrence in different climatesA replication-incompetent PB2-knockout influenza A virus vaccine vector.Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, ThailandRecent developments in seasonal and pandemic influenza vaccines.
P2860
Q21135459-4C0C8212-86D9-4A22-8C2B-E753593FFF30Q28079669-AB6FFD86-4A92-476B-AED5-81D60290DA5BQ30218410-02E96985-1878-4290-B6C4-D5058DAB8307Q30375380-2BA18699-80DF-43D2-AA99-C21639D80387Q30382097-F2750092-D76B-415F-9144-D073B609283FQ33427870-32BD1488-5F95-4DE7-85E6-14973B66D1FFQ33554718-9E853BF6-9B0A-4C34-A8DB-988602DEFEDDQ34313957-DC59DBEE-9BA1-4D83-A039-27C252C1B483Q35193700-79639BDE-B4E1-42F1-9637-EE82382AE706Q35855766-34AF142C-4344-4FBC-921A-C7C3891B9C3BQ35868034-D244AB56-3145-4ABB-A4AC-B994AADD87DFQ36252462-433B8818-0699-43F2-9356-7F592937A14DQ43187096-0DB286F7-E7FA-48E5-AA75-89BB82515FF6
P2860
Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@ast
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@en
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@nl
type
label
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@ast
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@en
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@nl
prefLabel
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@ast
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@en
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@nl
P1476
Vaccines for pandemic influenz ...... to deal with a pandemic threat
@en
P2093
Alan W Hampson
P407
P577
2008-06-01T00:00:00Z